- Home
- NVCR vs PRA Comparison
NVCR vs PRA Comparison
Compare NVCR & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCR | PRA |
|---|---|---|
| Founded | 2000 | 1976 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NVCR | PRA |
|---|---|---|
| Price | $12.00 | $24.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $28.08 | $25.00 |
| AVG Volume (30 Days) | ★ 2.6M | 572.3K |
| Earning Date | 05-20-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.79 | N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | $655,353,000.00 | ★ $1,098,028,000.00 |
| Revenue This Year | $7.72 | N/A |
| Revenue Next Year | $6.74 | N/A |
| P/E Ratio | ★ N/A | $24.78 |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $15.30 |
| 52 Week High | $20.49 | $24.77 |
Technical Indicators
Market Signals| Indicator | NVCR | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 51.25 |
| Support Level | $10.86 | $23.88 |
| Resistance Level | $14.13 | $24.64 |
| Average True Range (ATR) | 1.00 | 0.12 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 25.37 | 28.00 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.